Roundup Lawsuit

Patients who have suffered complications, including non-Hodgkin’s lymphoma after being exposed to Roundup may be eligible to pursue a claim and seek financial compensation.

Roundup is a herbicide primarily used for weed growth in residential, agricultural and industrial crops. It was originally produced by Monsanto Corporation, up until the company was acquired by Bayer in 2018. It’s active ingredient, glyphosate, is a possible carcinogen. As a result, thousands of affected patients and family members have filed lawsuits against the company, claiming that Monsanto failed to warn users of Roundup about the risk of developing non-Hodgkin’s lymphoma and other forms of cancer.

If you or a loved one was significantly exposed to Roundup and developed non-Hodgkin’s Lymphoma or other forms of cancer, contact Maxwell Law Group LLP today. We can answer your questions and review your case for free.

Roundup is a grass and weed killer originally intended for small-scale use in residences, and smaller farms. It was developed, patented, and marketed by Monsanto Corporation, releasing it to the market in 1973. In 1996, the company unveiled the first of Roundup Ready crops—produce which were genetically engineered to withstand the herbicide. This led to widespread agricultural and industrial use of Roundup.

In 2015, it is estimated that the company made over $4.76 billion in sales and $1.9 billion in gross profits from herbicide products, with the majority coming from Roundup. In 2018, Bayer acquired Monsanto for $66 billion.

Anyone who meets the following criteria may be eligible to file a Roundup lawsuit:

• Individuals who were regularly exposed to glyphosate-based herbicide and were diagnosed with non-Hodgkin's lymphoma, including those who:
  • Presently do not require treatment
  • Previously received treatment
• Immediate family members of an individual who passed away due to non-Hodgkin's lymphoma from regular glyphosate-based herbicide exposure

Roundup has an active ingredient called glyphosate which inhibits the enzyme EPSP synthase in plants. Without it, plants will not be able to produce the needed proteins to grow, thus turning yellow and dying within days or weeks.

Glyphosate is one of the most widely used herbicides in the US since its release in 1973. Glyphosate comes in both solid or liquid forms. It can cause irritation in the skin, eyes, nose, and throat. Swallowing glyphosate can cause increased salivation, mouth and throat burn, nausea, vomiting, and diarrhea.

There has been conflicting data from government and scientific agencies whether glyphosate is a carcinogen to humans or not.

In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) published a study that looked into glyphosate. It classified glyphosate as a probable carcinogenic to humans under group 2A. This category means there is there is limited evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals.

However, in December 2017, the Environmental Protection Agency (EPA) released draft risk assessments for glyphosate. It concluded that glyphosate is not likely to be a carcinogen among humans, and that no other meaningful risks are observed with the chemical’s use. The agency evaluated glyphosate exposure from different industries, and performed an in-depth review of the glyphosate cancer database, including data from epidemiological, animal carcinogenicity, and genotoxicity studies.

The FDA posted a Q&A page for glyphosate, discussing the agency’s role on regulation, safety concerns, and testing results.

The FDA’s role is to ensure that trace amounts of pesticides in harvested crops do not exceed the established limits by the EPA. The FDA acknowledged the EPA’s evaluation of glyphosate, but they also mentioned the IARC’s conclusion that glyphosate may be a carcinogen.

Glyphosate is banned in several countries, including:

• Belgium
• Bermuda
• Colombia
• Germany
• Netherlands
• Sri Lanka
• El Salvador
• France

Other European countries are also in the process of banning the herbicide following the health concerns raised by the IARC.

The time you have to pursue a claim is limited. Do not wait to reach out to our firm or call (844) 525-7155 to see if you have a case.

There had been conflicting studies about the association of glyphosate and cancer—some concluding that glyphosate is a probable cause of cancer, while other studies have shown no connection between the two.

However, during a recent trial involving Roundup, it was revealed that Monsanto worked with a third party consulting firm to publish an “independent” review of Roundup’s effects on the body. Published in 2016, the study was designed as a rebuttal to IARC’s 2015 findings on glyphosate.

Moreover, emails from Monsanto’s product protection department revealed that they tried to combat studies that are critical of the product. The department lead even wrote to colleagues on how to publicly talk about the science of Roundup, instructing them to say that Roundup does not cause cancer. The document also revealed plans of ghostwriting from the company favoring research that finds the product safe and without risk.

Over the years, the WHO has defended its stance on their findings about glyphosate, issuing several letters and responses to organizations and news outlets that question or challenge their classification of the chemical.

In 2016, a school groundskeeper filed a lawsuit against Monsanto on the grounds that Roundup contributed significantly to the development of non-Hodgkin’s lymphoma, a type of blood cancer. Dewayne Johnson’s diagnosis is terminal, and doctors estimated that he had months to live. The jury gave their verdict in August 2018, awarding him with $289 million. The jury determined that Roundup caused his cancer, and that the company failed to properly warn him of its dangers. Moreover, they found Monsanto guilty of acting with malice or oppression. The presiding Judge later reduced the punitive damages from $250 million to $39 million—but did not overturn the verdict against Monsanto.

The second jury also found Roundup responsible for a 70-year old man's cancer. In March 2019, the jury in San Francisco federal civil court awarded more than $80 million in damages to a plaintiff who developed non-Hodgkin’s lymphoma after using the weedkiller for 26 years.

In May 2019, a California jury ordered Monsanto to pay a couple $2 billion in damages after concluding that Roundup caused them to develop cancer. The couple used the Roundup for decades in their property, and were both diagnosed with non-Hodgkin’s lymphoma. In July 2019, the judge slashed the amount to $86 million, citing that the billion-dollar punitive damage awards were excessive and unconstitutional. The judge, however, rejected Bayer’s request to completely remove the punitive award amount.

In October 2021, Bayer won the verdict over a claim that the herbicide caused a child to develop rare form of non-Hodgkin's lymphoma. This is the fourth verdict involving Roundup and the first to favor Bayer.

In June 2020, Bayer announced a settlement of roughly $10.9 billion to resolve a large share of the Roundup claims pending at the time. In June 2022, the U.S. Supreme Court declined to hear Monsanto’s appeal of the Pilliod verdict, leaving it in place. Juries continued to return verdicts on both sides in the years that followed, including a $78 million award by a Philadelphia jury in October 2024.

In February 2026, Monsanto announced a proposed nationwide class settlement of up to $7.25 billion, paid over as many as 21 years, to resolve current and future Roundup claims alleging non-Hodgkin’s lymphoma. A Missouri court in St. Louis granted preliminary approval in March 2026 and held a final approval hearing on September 14, 2026.

On June 25, 2026, the U.S. Supreme Court ruled 7–2 in Monsanto Co. v. Durnell that federal pesticide law preempts state-law claims that Monsanto failed to warn of a cancer risk on the Roundup label where the EPA has not required that warning. The decision significantly narrowed one of the main legal theories in Roundup cases. Other claims, such as design defect, negligence and fraud, are not directly addressed by that ruling, and every case depends on its own facts. If you were exposed to Roundup and diagnosed with non-Hodgkin’s lymphoma, contact our firm to discuss your options.

If you or your loved one developed non-Hodgkin’s lymphoma or other types of cancer after being exposed to Roundup, Maxwell Law Group can help get you the compensation you deserve. Call (844) 525-7155 or fill out the form below and we’ll investigate your case at no charge to you.